Skip to main content

Shawver Laura

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Shawver Laura as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

SPRY ARS Pharmaceuticals, Inc.

Director12 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 8, 2025 (view filing)Apr 71 dayShawver LauraDirectorSSale−50.0K$12.30−$615.0K−19.2%210.3K after10b5-1
Mar 7, 2025 (view filing)Mar 5-62 daysShawver LauraDirectorSSale−50.0K$11.21−$560.4K−19.2%210.3K after2 lots10b5-1
Feb 4, 2025 (view filing)Feb 31 dayShawver LauraDirectorSSale−50.0K$12.31−$615.5K−19.2%210.3K after10b5-1
Jan 7, 2025 (view filing)Jan 61 dayShawver LauraDirectorSSale−50.0K$11.10−$555.0K−19.2%210.3K after10b5-1
Dec 4, 2024 (view filing)Dec 2-42 daysShawver LauraDirectorSSale−200.0K$13.44−$2.69M−48.7%210.3K after4 lots10b5-1
Sep 5, 2023 (view filing)Sep 14 daysShawver LauraDirectorSSale−100.0K$7.71−$771.0K−32.2%210.3K after10b5-1
Aug 7, 2023 (view filing)Aug 3-44 daysShawver LauraDirectorSSale−45.0K$7.03−$316.4K−17.6%210.3K after2 lots10b5-1
Aug 3, 2023 (view filing)Aug 1-22 daysShawver LauraDirectorSSale−55.0K$7.12−$391.8K−20.7%210.3K after2 lots10b5-1
Jul 7, 2023 (view filing)Jul 7Same dayShawver LauraDirectorSSale−8.86K$6.36−$56.3K−4.0%210.3K after
Jul 6, 2023 (view filing)Jul 3-63 daysShawver LauraDirectorSSale−91.1K$6.48−$590.4K−30.2%210.3K after3 lots

See all 12 trades at SPRY